If the newsletter is not displayed properly, please visit our website >>> 


Newsletter October 2017

EPO received full AAALAC accreditation

The AAALAC accreditation is a major achievement for EPO’s operation as international service provider for preclinical oncology.

With more than 20 years experience EPO is offering:

Tumor models for in vivo drug screening:
  • more than 500 PDX models
  • immune oncology models  (including humanized mice)
  • orthotopic  and metastasizing tumor models
EPO is providing laboratories with high hygienic, veterinarian and quality standards.
  • Biosafety S1 or S2 laboratories
  • Tumor irradition and studies with radioactive isotopes
  • Tumor imaging (bioluminescence and ultrasound)
  • Board certified pathology
EPO performs your comprehensive, tailored preclinical study with high flexibility and intense communication.



For more informations visit our Web site: www.epo-berlin.com or contact 
jens.hoffmann@epo-berlin.com

Impress:

EPO Experimental Pharmacology & Oncology Berlin-Buch GmbH
Robert-Rössle-Straße 10, Haus 82
13125 Berlin Germany

Amtsgericht Charlottenburg,Sitz Berlin, HRB 61814


If you no longer wish to receive this newsletter, please click on unsubscibe.

Copyright:EPO GmbH© 2017